Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06351332
Status:
SUSPENDED
Last Update Posted:
2024-06-20
First Post:
2024-04-02
Brief Title:
ZAP-IT ZN-c3 Carboplatin Pembrolizumab in MTNBC
Sponsor:
Filipa Lynce MD
Organization:
Dana-Farber Cancer Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-01
Start Date Type:
ACTUAL
Primary Completion Date:
2027-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-09-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-02
First Submit QC Date:
April 2 2024
Study First Post Date:
2024-04-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-11
Last Update Post Date:
2024-06-20
Last Update Post Date Type:
ACTUAL